Schmitz et al. (2018)
Summary of novel genes
| Entity | Tier 1 genes | Tier 2 genes | Tier 3 genes |
|---|---|---|---|
| DLBCL | 4 | 14 | 0 |
---
config:
sankey:
showValues: true
linkColor: target
width: 600
height: 300
nodeAlignment: right
prefix: '('
suffix: ' genes)'
---
sankey-beta
This study, New Tier 1, 4
New Tier 1, DLBCL Tier 1, 4
This study, New Tier 2, 14
New Tier 2, DLBCL Tier 2, 14
This study, New Tier 3, 0
New Tier 3, DLBCL Tier 3, 0
All other DLBCL studies, DLBCL Tier 1, 121
All other DLBCL studies, DLBCL Tier 2, 196
All other DLBCL studies, DLBCL Tier 3, 387
Novel genes reported in this study
Tier 1
| New gene | DLBCL tier |
|---|---|
| GRHPR | 1 |
| ITPKB | 1 |
| NOL9 | 1 |
| WEE1 | 1 |
Tier 2
| New gene | DLBCL tier |
|---|---|
| CXCR5 | 2 |
| EIF2AK3 | 2 |
| FOXC1 | 2 |
| GPC5 | 2 |
| GSG2 | 2 |
| ID3 | 2 |
| KLHL21 | 2 |
| LAMA5 | 2 |
| MYBPC2 | 2 |
| PAPOLG | 2 |
| PRKDC | 2 |
| SEL1L3 | 2 |
| TAP1 | 2 |
| UBE2J1 | 2 |
Details
Schmitz, Roland, George W. Wright, Da Wei Huang, Calvin A. Johnson,
James D. Phelan, James Q. Wang, Sandrine Roulland, et al. 2018.
“Genetics and Pathogenesis of Diffuse Large
B-Cell Lymphoma.” The New England Journal of
Medicine 378 (15): 1396–1407. https://doi.org/10.1056/NEJMoa1801445.

